top of page
  • LinkedIn
  • Instagram
  • Facebook

Value Through Evidence

We specialise in engaging hard-to-reach populations to generate crucial data and transform it into actionable evidence. Our expertise spans real-world evidence (RWE), preference research, and health economics and outcomes research (HEOR). Our in-house team conducts industry-standard qualitative, quantitative, and mixed-methods research in collaboration with our trusted partners.

Preference Research and Real World Outcomes

What we do

Real World Datasets

We collaborate with community partners to curate real world datasets, encompassing both primary data (patient reported) and secondary data (e.g. health records).

​

Our unified datasets are used to support evidence based advocacy, health policy decisions making and pharmaceutical development throughout all phases (pre-clinical through to post-marketing). 

Primary Research

We conduct primary research with stakeholders, including patients, caregivers, healthcare professionals and more. â€‹Our primary research studies include:  

 

  • Preference exploration and elicitation (e.g. Discrete Choice Experiments)

  • Quality of life/health state utility studies

  • Direct to patient/caregiver surveys

  • Observational studies (including phase 4 follow up studies)

  • and more. 

HEOR Services

We are trained health economists with experience apply the best health economic techniques to complex problems. We provide HEOR services such as: 

​

  • Secondary data sourcing, integration and analysis

  • Economic and Decision Modelling 

  • Patient Reported Outcome Measure Development and Evaluation

  • General Population Research including health state utilities, disability paradox studies and other foundation concepts to inform health outcomes. 

  • and more

Comprehensive Research Support Services

Alongside our core competencies, we also provide comprehensive research support services, which include: 

​

  • Digital Health Technology, Ethics and Data Linkage

  • Evidence Synthesis 

  • Advanced Statistical Analysis

  • Scientific, Medical and Value Communications 

  • Internal and External Evidence Dissemination  

And more

We have a broad skill set with capabilities to support a wide range of needs, if you have a question about something not covered on this website, reach out to us. 

Who our work supports

We believe in providing high quality robust evidence centred around the people affected by a condition

We support Pharmaceutical, Biotechnology and Medical Device companies. Specialising in rare disease.

We support healthcare systems and providers make decisions with high quality evidence.

Patient Organisations

We support Patient Advocacy Groups with evidence based advocacy.

Anchor 1

Our Partners

Our Leadership Team

Leveraging combined expertise.

DHT was established by Sam Bristow and George Morgan. Their aim was to bridge the gap between pharmaceutical innovation and the real-world needs of patients and their families. With a deep passion for data-driven solutions, they began by developing the PIVOT methodology in collaboration with patient advocacy groups and lived experience experts, laying the foundation to build upon. Today, DHT combines cutting-edge research, patient-centred insights, and collaboration to create meaningful change for those impacted by a health condition.

​

Their vision is a world where individuals with a health condition, benefit from much-needed research, high quality data, and personalised healthcare solutions.

Profile Pi.jpg

Don't take our word for it

Kate Burt - The Haemophilia Society

Sam Bristow has for a number of years been a strategic advisor to the Haemophilia Society, a UK charity that supports people with genetic bleeding disorders. His expertise in evidence based decision making has helped us demonstrate our impact, secure funding and give people with bleeding disorders greater understanding of an access to the best treatment options available. 

Kate Burt, CEO of The Haemophilia Society

Latest News & Insights

bottom of page